|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 37, 1625-1632, Copyright © 1996 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
BM Kenyon, EE Voest, CC Chen, E Flynn, J Folkman and RJ D'Amato
Department of Surgery, Children's Hospital, Boston, Massachusetts 02115, USA.
PURPOSE: The study of angiogenesis depends on reliable and reproducible models for the stimulation of a neovascular response. The purpose of this research was to develop such a model of angiogenesis in the mouse cornea. METHODS: Uniformly sized Hydron pellets containing either basic fibroblast growth factor (bFGF) or vascular endothelial growth factor (VEGF) and sucralfate were prepared and implanted into the stroma mouse cornea adjacent to the temporal limbus. RESULTS: Neovascularization of the corneal stroma began on day 3 and was sustained through day 8. The bFGF-induced neovascularization was consistent and dose dependent in C57B1/6, as well as in severe combined immune deficient, beige natural killer cell-deficient, and nude mouse strains. Biomicroscopic and histologic examination of bFGF- and VEGF-induced angiogenesis was notable for the absence of corneal edema or substantial inflammation. CONCLUSIONS: This noninflammatory model of corneal neovascularization is especially advantageous because it is reproducible, economical, and facilitates investigation of angiogenesis in various murine tumor models as well as in genetically defined murine strains.
This article has been cited by other articles:
![]() |
U. Tigges, E. G. Hyer, J. Scharf, and W. B. Stallcup FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages Development, February 1, 2008; 135(3): 523 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schwartz, J. George, J. Ben-Shoshan, G. Luboshits, I. Avni, H. Levkovitch-Verbin, H. Ziv, M. Rosner, and A. Barak Drug Modification of Angiogenesis in a Rat Cornea Model Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 250 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. You, C.-H. Yang, J.-S. Huang, M.-S. Chen, and C.-M. Yang Fractalkine, a CX3C Chemokine, as a Mediator of Ocular Angiogenesis Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5290 - 5298. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Rogers, K. A. Christensen, A. E. Birsner, S. M. Short, D. J. Wigelsworth, R. J. Collier, and R. J. D'Amato Mutant Anthrax Toxin B Moiety (Protective Antigen) Inhibits Angiogenesis and Tumor Growth Cancer Res., October 15, 2007; 67(20): 9980 - 9985. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar, V. B. Knick, S. K. Rudolph, J. H. Johnson, R. M. Crosby, M.-C. Crouthamel, T. M. Hopper, C. G. Miller, L. E. Harrington, J. A. Onori, et al. Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity Mol. Cancer Ther., July 1, 2007; 6(7): 2012 - 2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Umans, L. Cox, M. Tjwa, V. Bito, L. Vermeire, K. Laperre, K. Sipido, L. Moons, D. Huylebroeck, and A. Zwijsen Inactivation of Smad5 in Endothelial Cells and Smooth Muscle Cells Demonstrates that Smad5 Is Required for Cardiac Homeostasis Am. J. Pathol., May 1, 2007; 170(5): 1460 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Udagawa, A. E. Birsner, M. Wood, and R. J. D'Amato Chronic Suppression of Angiogenesis following Radiation Exposure Is Independent of Hematopoietic Reconstitution Cancer Res., March 1, 2007; 67(5): 2040 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishiwaki, M. Yoshida, H. Iwaguro, H. Masuda, N. Nitta, T. Asahara, and M. Isobe Endothelial E-Selectin Potentiates Neovascularization via Endothelial Progenitor Cell-Dependent and -Independent Mechanisms Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 512 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takeda, A. R. Kazarov, C. E. Butterfield, B. D. Hopkins, L. E. Benjamin, A. Kaipainen, and M. E. Hemler Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro Blood, February 15, 2007; 109(4): 1524 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kojima, J.-H. Chang, and D. T. Azar Proangiogenic Role of ephrinB1/EphB1 in Basic Fibroblast Growth Factor-Induced Corneal Angiogenesis Am. J. Pathol., February 1, 2007; 170(2): 764 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cursiefen, L. Chen, M. Saint-Geniez, P. Hamrah, Y. Jin, S. Rashid, B. Pytowski, K. Persaud, Y. Wu, J. W. Streilein, et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision PNAS, July 25, 2006; 103(30): 11405 - 11410. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dell, S. Peters, P. Muther, N. Kociok, and A. M. Joussen The Role of PDGF Receptor Inhibitors and PI3-Kinase Signaling in the Pathogenesis of Corneal Neovascularization Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1928 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kertesz, V. Krasnoperov, R. Reddy, L. Leshanski, S. R. Kumar, S. Zozulya, and P. S. Gill The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth Blood, March 15, 2006; 107(6): 2330 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ueda, U. Ozerdem, Y.-H. Chen, M. Yao, K. T. Huang, H. Sun, M. Martins-Green, P. Bartolini, and A. M Walker A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone. Endocr. Relat. Cancer, March 1, 2006; 13(1): 95 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Oshima, K-H Sonoda, C Tsutsumi-Miyahara, H Qiao, T Hisatomi, S Nakao, S Hamano, K Egashira, I F Charo, and T Ishibashi Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice Br. J. Ophthalmol., February 1, 2006; 90(2): 218 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kisucka, C. E. Butterfield, D. G. Duda, S. C. Eichenberger, S. Saffaripour, J. Ware, Z. M. Ruggeri, R. K. Jain, J. Folkman, and D. D. Wagner Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage PNAS, January 24, 2006; 103(4): 855 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. LaMontagne, A. Littlewood-Evans, C. Schnell, T. O'Reilly, L. Wyder, T. Sanchez, B. Probst, J. Butler, A. Wood, G. Liau, et al. Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis and Tumor Vascularization Cancer Res., January 1, 2006; 66(1): 221 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, J.-x. Ma, G. Gao, C. Li, L. Luo, M. Zhang, W. Yang, A. Jiang, W. Kuang, L. Xu, et al. Plasminogen Kringle 5 Inhibits Alkali-Burn-Induced Corneal Neovascularization Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4062 - 4071. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ozerdem, K. Alitalo, P. Salven, and A. Li Contribution of Bone Marrow-Derived Pericyte Precursor Cells to Corneal Vasculogenesis Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3502 - 3506. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Biswas, K. Banerjee, B. Kim, P. R. Kinchington, and B. T. Rouse Role of Inflammatory Cytokine-Induced Cycloxygenase 2 in the Ocular Immunopathologic Disease Herpetic Stromal Keratitis J. Virol., August 15, 2005; 79(16): 10589 - 10600. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Filleur, K. Volz, T. Nelius, Y. Mirochnik, H. Huang, T. A. Zaichuk, M. S. Aymerich, S. P. Becerra, R. Yap, D. Veliceasa, et al. Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer Cancer Res., June 15, 2005; 65(12): 5144 - 5152. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Morisada, Y. Oike, Y. Yamada, T. Urano, M. Akao, Y. Kubota, H. Maekawa, Y. Kimura, M. Ohmura, T. Miyamoto, et al. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation Blood, June 15, 2005; 105(12): 4649 - 4656. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Hayashi, T. Asahara, H. Masuda, J. M. Isner, and D. W. Losordo Functional Ephrin-B2 Expression for Promotive Interaction Between Arterial and Venous Vessels in Postnatal Neovascularization Circulation, May 3, 2005; 111(17): 2210 - 2218. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Shi, G.-Y. Shi, Y.-S. Chang, H.-S. Han, C.-H. Kuo, C. Liu, H.-C. Huang, Y.-J. Chang, P.-S. Chen, and H.-L. Wu Evidence of Human Thrombomodulin Domain as a Novel Angiogenic Factor Circulation, April 5, 2005; 111(13): 1627 - 1636. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hirakawa, S. Fujii, K. Kajiya, K. Yano, and M. Detmar Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage Blood, March 15, 2005; 105(6): 2392 - 2399. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chen, M. Guo, D. Wygle, P. A. Edwards, J. R. Falck, R. J. Roman, and A. G. Scicli Inhibitors of Cytochrome P450 4A Suppress Angiogenic Responses Am. J. Pathol., February 1, 2005; 166(2): 615 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kim, Q. Tang, P. S. Biswas, J. Xu, R. M. Schiffelers, F. Y. Xie, A. M. Ansari, P. V. Scaria, M. C. Woodle, P. Lu, et al. Inhibition of Ocular Angiogenesis by siRNA Targeting Vascular Endothelial Growth Factor Pathway Genes: Therapeutic Strategy for Herpetic Stromal Keratitis Am. J. Pathol., December 1, 2004; 165(6): 2177 - 2185. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Park, D. Crouse, M. Lee, S. K. Karnik, L. K. Sorensen, K. J. Murphy, C. J. Kuo, and D. Y. Li The axonal attractant Netrin-1 is an angiogenic factor PNAS, November 16, 2004; 101(46): 16210 - 16215. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huang, S. C. Campbell, D. F. Bedford, T. Nelius, D. Veliceasa, E. H. Shroff, J. Henkin, A. Schneider, N. Bouck, and O. V. Volpert Peroxisome Proliferator-Activated Receptor {gamma} Ligands Improve the Antitumor Efficacy of Thrombospondin Peptide ABT510 Mol. Cancer Res., October 1, 2004; 2(10): 541 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ma, P. Ottino, H. E. P. Bazan, and N. G. Bazan Platelet-Activating Factor (PAF) Induces Corneal Neovascularization and Upregulates VEGF Expression in Endothelial Cells Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2915 - 2921. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Chang, G. Garcia-Cardena, F. Farnebo, M. Fannon, E. J. Chen, C. Butterfield, M. A. Moses, R. C. Mulligan, J. Folkman, and A. Kaipainen Dose-dependent response of FGF-2 for lymphangiogenesis PNAS, August 10, 2004; 101(32): 11658 - 11663. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. ROGERS, R. M. ROHAN, A. E. BIRSNER, and R. J. D'AMATO Genetic loci that control the angiogenic response to basic fibroblast growth factor FASEB J, July 1, 2004; 18(10): 1050 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yu, K. S. Moulton, M. K. Khan, S. Vineberg, E. Boye, V. M. Davis, P. E. O'Donnell, J. Bischoff, and D. S. Milstone E-selectin is required for the antiangiogenic activity of endostatin PNAS, May 25, 2004; 101(21): 8005 - 8010. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Usui, S. Ishida, K. Yamashiro, Y. Kaji, V. Poulaki, J. Moore, T. Moore, S. Amano, Y. Horikawa, D. Dartt, et al. VEGF164(165) as the Pathological Isoform: Differential Leukocyte and Endothelial Responses through VEGFR1 and VEGFR2 Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 368 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Chan, L. N. Pham, C. Chinn, C. Spee, S. J. Ryan, R. J. Akhurst, and D. R. Hinton Mouse Strain-Dependent Heterogeneity of Resting Limbal Vasculature Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wasmuth, D. Bauer, Y. Yang, K.-P. Steuhl, and A. Heiligenhaus Topical Treatment with Antisense Oligonucleotides Targeting Tumor Necrosis Factor-{alpha} in Herpetic Stromal Keratitis Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5228 - 5234. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Beebe, J. P. Jani, E. Knauth, P. Goodwin, C. Higdon, A. M. Rossi, E. Emerson, M. Finkelstein, E. Floyd, S. Harriman, et al. Pharmacological Characterization of CP-547,632, a Novel Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for Cancer Therapy Cancer Res., November 1, 2003; 63(21): 7301 - 7309. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ito, Y. Oike, K. Yasunaga, K. Hamada, K. Miyata, S.-i. Matsumoto, S. Sugano, H. Tanihara, Y. Masuho, and T. Suda Inhibition of Angiogenesis and Vascular Leakiness by Angiopoietin-Related Protein 4 Cancer Res., October 15, 2003; 63(20): 6651 - 6657. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zheng, C. Wasylyk, A. Ayadi, J. Abecassis, J. A Schalken, H. Rogatsch, N. Wernert, S.-M. Maira, M.-C. Multon, and B. Wasylyk The transcription factor Net regulates the angiogenic switch Genes & Dev., September 15, 2003; 17(18): 2283 - 2297. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Licht, L. Tsirulnikov, H. Reuveni, T. Yarnitzky, and S. A. Ben-Sasson Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3) Blood, September 15, 2003; 102(6): 2099 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Patel, L. Sun, D. Moshinsky, H. Chen, K. M. Leahy, P. Le, K. G. Moss, X. Wang, A. Rice, D. Tam, et al. A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular Permeability J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 838 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Rakoczy, M. Brankov, A. Fonceca, T. Zaknich, B. C. Rae, and C.-M. Lai Enhanced Recombinant Adeno-Associated Virus-Mediated Vascular Endothelial Growth Factor Expression in the Adult Mouse Retina: A Potential Model for Diabetic Retinopathy Diabetes, March 1, 2003; 52(3): 857 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamada, Y. Oike, H. Ogawa, Y. Ito, H. Fujisawa, T. Suda, and N. Takakura Neuropilin-1 on hematopoietic cells as a source of vascular development Blood, March 1, 2003; 101(5): 1801 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Ambati, A. Anand, A. M. Joussen, W. A. Kuziel, A. P. Adamis, and J. Ambati Sustained Inhibition of Corneal Neovascularization by Genetic Ablation of CCR5 Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 590 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Stuart, F. Pan, S. Plambeck, and T. A. Ferguson FasL-Fas Interactions Regulate Neovascularization in the Cornea Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Auerbach, R. Lewis, B. Shinners, L. Kubai, and N. Akhtar Angiogenesis Assays: A Critical Overview Clin. Chem., January 1, 2003; 49(1): 32 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Cursiefen, C Hofmann-Rummelt, M Kuchle, and U Schlotzer-Schrehardt Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation Br. J. Ophthalmol., January 1, 2003; 87(1): 101 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. CHANG, A. KAIPAINEN, and J. FOLKMAN Lymphangiogenesis New Mechanisms Ann. N.Y. Acad. Sci., December 1, 2002; 979(1): 111 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cheng, D. M. Brantley, H. Liu, Q. Lin, M. Enriquez, N. Gale, G. Yancopoulos, D. P. Cerretti, T. O. Daniel, and J. Chen Blockade of EphA Receptor Tyrosine Kinase Activation Inhibits Vascular Endothelial Cell Growth Factor-Induced Angiogenesis Mol. Cancer Res., November 1, 2002; 1(1): 2 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. CAO, E. BRAKENHIELM, X. LI, K. PIETRAS, J. WIDENFALK, A. OSTMAN, U. ERIKSSON, and Y. CAO Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-{alpha}{alpha} and -{alpha}{beta} receptors FASEB J, October 1, 2002; 16(12): 1575 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Corada, L. Zanetta, F. Orsenigo, F. Breviario, M. G. Lampugnani, S. Bernasconi, F. Liao, D. J. Hicklin, P. Bohlen, and E. Dejana A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability Blood, July 18, 2002; 100(3): 905 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Claffey Molecular Profiling of Angiogenic Markers : A Step Towards Interpretive Analysis of a Complex Biological Function Am. J. Pathol., July 1, 2002; 161(1): 7 - 11. [Full Text] [PDF] |
||||
![]() |
M. Zheng, D. M. Klinman, M. Gierynska, and B. T. Rouse DNA containing CpG motifs induces angiogenesis PNAS, June 25, 2002; 99(13): 8944 - 8949. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, C. Li, and P. C. Baciu Expression of Integrins and MMPs during Alkaline-Burn-Induced Corneal Angiogenesis Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 955 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, M. Zheng, S. Deshpande, S. K. Eo, T. A. Hamilton, and B. T. Rouse IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis J. Leukoc. Biol., March 1, 2002; 71(3): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Thyboll, J. Kortesmaa, R. Cao, R. Soininen, L. Wang, A. Iivanainen, L. Sorokin, M. Risling, Y. Cao, and K. Tryggvason Deletion of the Laminin {alpha}4 Chain Leads to Impaired Microvessel Maturation Mol. Cell. Biol., February 15, 2002; 22(4): 1194 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Huynh-Do, C. Vindis, H. Liu, D. P. Cerretti, J. T. McGrew, M. Enriquez, J. Chen, and T. O. Daniel Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis J. Cell Sci., January 8, 2002; 115(15): 3073 - 3081. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Du, J. Luan, H. Liu, T. O. Daniel, S. Peiper, T. S. Chen, Y. Yu, L. W. Horton, L. B. Nanney, R. M. Strieter, et al. Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress J. Leukoc. Biol., January 1, 2002; 71(1): 141 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zheng, M. A. Schwarz, S. Lee, U. Kumaraguru, and B. T. Rouse Control of Stromal Keratitis by Inhibition of Neovascularization Am. J. Pathol., September 1, 2001; 159(3): 1021 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U. Stechschulte, A. M. Joussen, H. A. von Recum, V. Poulaki, Y. Moromizato, J. Yuan, R. J. D'Amato, C. Kuo, and A. P. Adamis Rapid Ocular Angiogenic Control via Naked DNA Delivery to Cornea Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 1975 - 1979. [Abstract] [Full Text] [PDF] |